Sepsis due to Clostridium perfringens after second-trimester amniocentesis.
Hovav
Y
Y
Hornstein
E
E
Pollack
R N
RN
Yaffe
C
C
D000032:Abortion, Therapeutic; D000328:Adult; D000649:Amniocentesis / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D003016:Clostridium perfringens / Q000302:isolation & purification*; D005260:Female; D005738:Gas Gangrene / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D006801:Humans; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000209:etiology* / Q000382:microbiology / Q000628:therapy; D011262:Pregnancy Trimester, Second
D000900:Anti-Bacterial Agents